(PRWEB) May 26, 2005
Between 1992 and 1994, Linus Pauling and associates informed the world that non prescription substances called "Lp(a) binding inhibitors" prevent cardiovascular disease (CVD). Pauling stated that these substances will also destroy existing atherosclerotic plaque already growing in blood vessels.
There are first-hand reports that PaulingÂs therapy reverses end-stage heart disease, sometimes in as little as one month. The number of these seemingly miraculous reversals of incapacitated cardiovascular diseased patients increases daily. Reports that span more than a decade are posted at PaulingTherapy.com.
PaulingÂs rationale explains why the Lp(a) binding inhibitors, especially vitamin C and the essential amino acid lysine, exert such a strong anti-CVD effect inside human arteries. These substances diminish cellular growth which, if left unchecked, slowly narrow the arteries, decreasing blood flow and increasing the chances of heart attack or stroke.
"People have a right to be skeptical," says Owen Fonorow, President of the videoÂs distributor Intelisoft Multimedia, Inc., and co-founder of the Vitamin C Foundation. "Scams abound and people donÂt know what to believe and often rely on their doctors. Most highly educated people think it impossible that heart disease could be caused by a vitamin deficiency, and the entire medical profession and pharmaceutical industry somehow missed it. However, the idea that a lack of vitamin C causes heart disease is not new. For some reason the early work, and the later Pauling/Rath theory and experiments, are ignored as if they never existed. We are thankful that Linus Pauling decided to film a lecture making these ideas available on video. Significant portions of the video are now available as a web-stream which can be viewed on home computers."
Pauling and Dr. Matthias Rath published their Unified Theory paper in the Journal of Orthomolecular Medicine in 1989. The Linus Pauling heart disease video is less technical and describes a specific, noninvasive, nontoxic nutritional therapy for reversing heart disease.
PaulingÂs message is not hard to understand. The late scientist explains that the Lp(a) binding inhibitor effect is two-pronged:
#1. Vitamin C and lysine stimulate the production of collagen. The increased collagen supply prevents the onset or spread of cardiovascular disease by helping to heal arterial cracks (or lesions) caused by the wear and tear of the beating heart.
#2. Lp(a) binding inhibitors reverse atherosclerosis by inactivating the affinity that the "sticky" Lp(a) cholesterol has for the amino acid lysine. The second action of binding inhibitors disrupts the formation of the plaque.
"These two actions are complementary and much less risky than prescription drugs or common medical procedures for CVD," states Fonorow. "Pauling made his announcement after confirming experiments at his Institute. There are now thousands of reports referring to the plaque-destroying effect of the Pauling Therapy. After more than 10 years, there have been no reports of adverse reactions, even in severely incapacitated patients."
Cardiovascular related health problems comprise one-half of all causes of death in the USA. So far, the medical profession has failed to follow-up the Pauling/Rath discoveries. Medical researchers have not conducted their own studies to test the Pauling/Rath hypothesis that too little vitamin C elevates cholesterol levels, especially the Lp(a) variant that causes narrowing of blood vessels.
The National Institutes of Health have refused to fund studies, and there are no public reports of pharmaceutical researchers investigating the Pauling therapy.
Linus Pauling stated that a double-blind, placebo-controlled trial was not necessary because the vitamin and amino acid therapy is non toxic, its effect is so pronounced, and CVD is otherwise debilitating or fatal.
Several Lp(a) Binding Inhibitor formulas as dietary supplements are available without prescription.
The Linus Pauling video on Heart Disease: A Unified Theory of Cause and Cure, contains additional information for health professionals and may be obtained from PaulingTherapy.com, or by telephoning Intelisoft Multimedia at 800-894-9025, or 1-630-416-1438 outside the USA.
For more information or to schedule an interview with Owen Fonorow, please call Mike Till at 281/443-3634 or e-mail Mike at Mike.Till@vitamincfoundation.org.
# # #